Detalhe da pesquisa
1.
DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.
Nucleic Acids Res
; 50(14): 7873-7888, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35801925
2.
Sequence variants in the proximal promoter and +5.8-kb site of ABO in Koreans with weak B phenotypes.
Vox Sang
; 117(3): 442-446, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34651317
3.
Mechanistic insights into the dual role of CCAR2/DBC1 in cancer.
Exp Mol Med
; 55(8): 1691-1701, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37524873
4.
Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer.
Theranostics
; 11(2): 958-973, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33391515
5.
DBC1 regulates Wnt/ß-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.
Cell Death Dis
; 9(8): 831, 2018 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30082743
6.
DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.
Oncogene
; 37(10): 1326-1339, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29249800